Identification of the major transport pathway for the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium

Neuroscience

Volumn 75, Issue 1, 1996, Pages 37-41

  Dunigan, C D ^a   Shamoo, A E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; dopamine; dopamine transporter; kinetics; Parkinson's disease; PC12 cells

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINE UPTAKE; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT;

EID: 0030572749     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00266-7     Document Type: Article

References (25)

1. Bloomquist J., King E., Wright A., Mytilineou C., Kimura K., Castagnoli K., Castagnoli N. Jr. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. J. Pharmac. exp. Ther. 270:1994;822-830.
2. Buck K. J., Amara S. G. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. natn. Acad. Sci. U.S.A. 91:1994;12584-12588.
3. Burns R. S. Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review. Acta neurol. scand. 84:1991;29-36.
4. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membrane Biochem. 7:1988;87-106.
5. Cao C. J., Eldefrawi A. T., Eldefrawi M. E. ATP-regulated neuronal CA uptake: a new mechanism. Life Sci. 47:1990;655-667.
6. Cao C. J., Shamoo A. E., Eldefrawi M. E. Cocaine sensitive, ATP-dependent dopamine uptake into striatal synaptosomes. Biochem. Pharmac. 39:1990;R9-R14.
7. Daniels A. J., Reinhard J. F. Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J. biol. Chem. 263:1988;5034-5036.
8. Denton T., Howard B. A dopaminergic cell line variant resistant to 1-methyl-4-phenylpyridinium. J. Neurochem. 49:1987;622-630.
9. + stimulates ATP-regulated DA uptake in PC12 cells. Neuroscience. 65:1995;1-4.
10. Eshleman A., Dunigan C. D., Shamoo A. E., Eldefrawi M. ATP enhances catecholamine uptake into PC12 cells. Life Sci. 56:1995;1613-1621.
11. Gerlach M., Riederer P., Youdim M. B. H. The molecular pharmacology of L-deprenyl. Eur. J. Pharmac. 226:1992;97-108.
12. Greene L. A., Rein G. Release, storage, and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129:1977;246-263.
13. Greene L. A., Tischler A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. natn. Acad. Sci. U.S.A. 73:1976;2424-2428.
14. Irwin I., Langston J. W. II. Selective accumulation of MPP in the substantia nigra: a key to neurotoxicity? Life Sci. 36:1985;207-212.
15. Iversen L. L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmac. 41:1971;571-591.
16. Javitch J. A., Snyder S. H. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur. J. Pharmac. 106:1985;455-456.
17. Jenner P., Shapira A. H. V., Marsden C. D. New insights into the cause of Parkinson's disease. Neurology. 42:1992;2241-2250.
18. Koide M., Cho A. K., Howard B. D. Characterization of xylamine binding to proteins. J. Neurochem. 47:1986;1277-1285.
19. Liu Y., Roghani A., Edwards R. H. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. natn. Acad. Sci. U.S.A. 89:1992;9074-9078.
20. Markey S. P., Johannessen J. N., Chiveh C. C., Burns R. S., Herkenham M. A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature. 3:1984;464-467.
21. Pifl C. P., Giros B., Caron M. G. Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13:1993;4246-4253.
22. Schapira A. H. V. Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Movement Disord. 9:1994;125-138.
23. Silinsky E. M. On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J. Physiol. 247:1975;145-162.
24. Sziraki I., Kardos V., Patthy M., Patfalusi M., Buda G. Methamphetamine protects against MPTP neurotoxicity in C57BL mice. Eur. J. Pharmac. 251:1994;311-314.
25. White T. D., Bourke J. E., Livett B. G. Direct and continuous detection of ATP secretion from primary monolayer cultures of bovine adrenal chromaffin cells. J. Neurochem. 49:1987;1266-1273.